PayPal (PYPL): Is Its Low Earnings Multiple a Bargain or a Value Trap?
PayPal Holdings Inc. (NASDAQ:PYPL) was down 6.6% year-to-date after closing at $54.61 on October 6.
Insider Monkey Blog
Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
Pune, India, October 6th, 2026, FinanceWire This is a paid advertisement. Quantum BioPharma Ltd.
Hedge Fund Investor Letters Q3 2026
In this article, we will share the hedge fund investor letters for the second quarter of 2026.
QXO (QXO): 61% Drawdown Creates an Asymmetric 37% Annualized Return Opportunity
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy”.
Billionaire Mario Gabelli Portfolio: A Waste Management Stock You Shouldn’t Miss
Republic Services, Inc. (NYSE:RSG) collects and disposes of waste in the U.S. and Canada.
A7 to Unveil a Service That Will Re-Invent the International Payments Market
Moscow, Russia, October 12th, 2026, FinanceWire On 13 October, the Russian international settlement system A7, created by Bank PSB, is set to present A7 International, a service...
Sirmium Capital’s Q3 2026 Investor Letter
Sirmium Capital recently released its quarterly Q3 2026 investor letter.
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy”.
What Makes Chime Financial (CHYM) A Long-Term Compounder?
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy”.
United Healthcare (UNH): Early-Stage Earnings Recovery Sets the Stage for Mid-Teens Compound Growth
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy”.
Royalty Pharma (RPRX) Offers Attractive Risk-Reward Profiles at Reasonable Multiples
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy”.
Avery Dennison (AVY): Is the Earnings Discount Justified After Customers Stop Stockpiling?
Avery Dennison Corporation (NYSE:AVY) makes labeling materials and identification products used across consumer goods, apparel, food, and logistics.
Packaging Corp. (PKG): Can Better Box Profits Justify Its Premium?
Packaging Corporation of America (NYSE:PKG) makes containerboard, the material used in corrugated boxes, and converts much of it into packaging for food, manufacturing, and retail...
Pilgrim’s Pride (PPC): Can Branded Chicken Growth Earn a Higher Valuation?
Pilgrim's Pride Corporation (NASDAQ:PPC) sells fresh and prepared chicken to retailers and foodservice customers, alongside its European pork and prepared-food operations.
Citigroup (C): Rebounding Return on Tangible Common Equity Anchors Long-Term Thesis
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy”.
10 Best Airline Stocks to Buy According to Hedge Funds
Taking a position in an airline stock means investing in a business that must turn travel demand into profit while managing costs it cannot fully control.
Patient Capital Management’s Q3 2026 Investor Letter
Patient Capital Management, based in Baltimore, released its third-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy”.
Apple (AAPL) Faces iPhone Demand Pressure. Can Its Growth Justify the Premium?
Apple Inc. (NASDAQ:AAPL) appears to be facing potential demand challenges for its latest iPhone models as rising memory-chip costs and higher prices weigh on consumers.
Broader Industry-Wide Volatility Weighs on ASML Holding NV (ASML)
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2026 investor letter for the “Baird Chautauqua...
Baird Chautauqua International and Global Growth Fund’s Q3 2026 Investor Letter
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2026 investor letter for the “Baird Chautauqua...
Guinness Global Real Assets Fund’s Q3 2026 Investor Letter
Guinness Global Investors recently released its "Global Real Assets Fund" August 2026 investor letter.
Can Ads and Subscriptions Justify Walmart’s (WMT) Premium Valuation?
Walmart’s shoppers come for low prices. Its shareholders are paying anything but.
CoreWeave (CRWV) Has a $104B Backlog. Can Its Balance Sheet Keep Up?
CoreWeave (NASDAQ:CRWV) has more work lined up than it can build for.
Moderna’s (MRNA) Cancer Vaccine Breakthrough Drives Sharp Stock Rally
Baillie Gifford & Co, an independent investment management firm, released its third-quarter 2026 investor letter for “US Equity Growth Strategy”.
Oracle (ORCL) Has $664B Lined Up. The Market Wants Cash First
Oracle (NYSE:ORCL) is sitting on a pile of signed business most companies can only dream about: $664 billion in remaining performance obligations (contracted revenue not yet recognized...
Qualcomm (QCOM) Has Amazon Now. Why Is It Still Priced Like a Phone Stock?
Qualcomm (NASDAQ:QCOM) signed one of the world’s biggest cloud operators as a long-term chip customer last month.
Nvidia (NVDA) Grows Like a Rocket But Still Looks Cheap
Nvidia (NASDAQ:NVDA) is posting the kind of numbers that once justified a sky-high price tag.
MercadoLibre (MELI) Trades Profit for Scale. Smart Bet or Warning?
MercadoLibre (NASDAQ:MELI) posted a quarter that looks like two different companies stapled together.
CrowdStrike (CRWD) Is Accelerating Again. Is 219 Times Earnings Too Far Ahead?
CrowdStrike Holdings (NASDAQ:CRWD) had what management called the best quarter in its history in fiscal Q2 2027.
How Microsoft (MSFT) Featured in the Third-Quarter Tech Recovery
Royce & Associates, LLC (operating as Royce Investment Partners) recently released its "Small Cap Fund" third-quarter 2026 investor letter.
Arm Holdings (ARM) Is Helping Reshape the Future of Computing: Here’s Why
St. James Investment Company recently released its "Value Investors" third-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Advanced Micro Devices (AMD) Found a Way to Challenge Intel’s Dominance
St. James Investment Company recently released its "Value Investors" third-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Coca-Cola (KO) Shows Why Strong Brands Can Build Lasting Competitive Moats
St. James Investment Company recently released its "Value Investors" third-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Intel (INTC) Lost Its Competitive Moat: What Went Wrong?
St. James Investment Company recently released its "Value Investors" third-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Why Taiwan Semiconductor (TSM) Became Essential to the Chip Industry
St. James Investment Company recently released its "Value Investors" third-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Apple (AAPL) Helped Lead the Mega-Cap Tech Rebound in Q3 2026
Royce & Associates, LLC (operating as Royce Investment Partners) recently released its "Small Cap Fund" third-quarter 2026 investor letter.
Royce’s Q3 Review Puts Meta (META) in the Spotlight
Royce & Associates, LLC (operating as Royce Investment Partners) recently released its "Small Cap Fund" third-quarter 2026 investor letter.
Shopify (SHOP): Building the Underlying Rails for the Era of Agentic Commerce
Baillie Gifford & Co, an independent investment management firm, released its third-quarter 2026 investor letter for “US Equity Growth Strategy”.
Paychex (PAYX): Does Its Payroll Moat Make the Earnings Discount Attractive?
Paychex, Inc. (NASDAQ:PAYX) earns recurring fees from payroll processing, tax compliance, and benefits administration.
Hormel (HRL): Can Foodservice Expansion Earn More Than its Cost of Capital?
Hormel Foods Corporation (NYSE:HRL) sells branded meats, prepared proteins, and grocery products through retailers, restaurants, and other foodservice customers.
Rollins (ROL): Can Repeat Customers Still Justify a Premium?
Rollins, Inc. (NYSE:ROL) provides pest control to households and businesses, earning revenue from repeat treatments, termite protection, and additional services.
Snowflake (SNOW) is Capitalizing on AI as a Demand Engine for Enterprise Data Workloads
Baillie Gifford & Co, an independent investment management firm, released its third-quarter 2026 investor letter for “US Equity Growth Strategy”.
KLA Corporation’s (KLAC) Critical Role in Zero-Tolerance Defect Environments
Baillie Gifford & Co, an independent investment management firm, released its third-quarter 2026 investor letter for “US Equity Growth Strategy”.
Kroger (KR) Combines a Low Valuation with a Growing Dividend
The Kroger Co. (NYSE:KR) is in a defensive sector since consumers keep purchasing groceries even when their household budgets are strained.
Can Gilead (GILD) Stock Continue Rising in 2027?
Gilead Sciences, Inc. (NASDAQ:GILD) shares are up more than 24% this year, ahead of the S&P 500’s 14%. Gilead makes HIV, liver disease and cancer drugs.
General Motors Stock Has a Low Valuation. Can it Sustain Earnings Growth?
General Motors Company (NYSE:GM) has a solid business involving trucks and SUVs in North America, along with financing activities and prospects in software-enabled services.
NextEra Energy Has Two Growth Drivers. Here’s What Investors Should Watch
NextEra Energy, Inc. (NYSE:NEE) has a regulated electric utility business as well as one of the largest renewable energy development operations in the United States.
ChatGPT Sells Broadcom (AVGO) and Buys This Online Retailer
ChatGPT recently sold all of its Broadcom Inc. (NASDAQ:AVGO) shares and moved the money into Chewy, Inc. (NYSE:CHWY), according to AI Finance Labs.
CVS Health’s Valuation Suggests Opportunity, but Can Earnings Deliver?
CVS Health Corporation (NYSE:CVS) operates across several areas of healthcare, including health insurance, pharmacy benefit management, and retail pharmacy services.
This Lesser-Known Stock Has Paid Consecutive Dividends Since 1939. Is Its Valuation Attractive Enough to Buy?
The attractiveness of Snap-on Incorporated (NYSE:SNA) investment lies in two main strengths: its long-standing record of rewarding shareholders and its capacity to produce large...
Hedge Fund Resource Center
